OrbiMed & Qiming Lead Minghui Pharma’s Pre-IPO Financing
08 Aug 2025
US$ 20.00
OrbiMed Advisors LLC and Qiming Venture Partners have co-led the US$131 m pre-IPO round of Minghui Pharmaceutical ......
Related Publications
Subscribers’ Weekly...
Listen to Australia/New Zealand Investments (Subscribers' Weekly 08 Aug 2025)...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.